Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Chemokine signaling pathway (mmu04062)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK044424
KLA  ATP  ATP+KLA
 AK044424 adult retina cDNA, RIKEN full-length enriched library, clone:A930012B14 product:unclassifiable, full insert sequence [AK044424] KLA .92 .86 .88 .88 .95 .83 1.05
ATP .85 .68 .74 .72 .83 1.06 1.04
KLA/ATP .86 .74 .78 .74 .80 .99 1.07
AK050363
KLA  ATP  ATP+KLA
 AK050363 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730040N22 product:unclassifiable, full insert sequence. [AK050363] KLA 1.00 .98 1.02 1.02 1.02 .92 .96
ATP .98 1.03 .93 .98 .96 1.02 .99
KLA/ATP 1.03 .96 .96 .95 1.02 .93 1.04
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adrbk1
KLA  ATP  ATP+KLA
 NM_130863 adrenergic receptor kinase, beta 1 (Adrbk1), mRNA [NM_130863] KLA .90 .84 .99 1.05 1.52 1.69 1.78
ATP 1.07 1.17 .92 1.19 .76 .60 1.08
KLA/ATP .93 .98 .66 .95 .63 .76 1.59
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Arrb1
KLA  ATP  ATP+KLA
 NM_177231 arrestin, beta 1 (Arrb1), transcript variant a, mRNA [NM_177231] KLA .41 .42 .32 .32 .31 .56 .80
ATP .97 .86 .81 .62 .47 .59 1.16
KLA/ATP .43 .37 .38 .36 .35 .35 .89
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
BC067047
KLA  ATP  ATP+KLA
 NM_177782 cDNA sequence BC067047 (BC067047), mRNA [NM_177782] KLA 1.84 1.64 1.87 1.94 2.60 3.15 2.37
ATP 1.08 1.10 1.19 1.29 1.26 1.19 1.82
KLA/ATP 1.88 1.63 1.96 2.02 1.59 2.28 3.23
BG242006
KLA  ATP  ATP+KLA
 BG242006 gb|602354740F1 NCI_CGAP_Mam1 Mus musculus cDNA clone IMAGE:4483064 5. [BG242006] KLA 2.25 2.23 2.26 2.70 2.56 2.67 1.45
ATP .92 .87 1.11 .97 .99 .97 .72
KLA/ATP 1.91 2.04 2.51 2.08 1.99 1.15 .67
Bcar1
KLA  ATP  ATP+KLA
 NM_009954 breast cancer anti-estrogen resistance 1 (Bcar1), mRNA [NM_009954] KLA .88 .87 .82 .88 1.06 1.12 1.70
ATP 1.04 1.05 1.00 1.27 1.34 1.62 1.34
KLA/ATP .95 .87 .87 .95 1.02 1.17 2.10
Braf
KLA  ATP  ATP+KLA
 NM_139294 Braf transforming gene (Braf), mRNA [NM_139294] KLA 1.52 1.57 1.55 1.33 1.83 1.52 1.60
ATP 1.08 1.17 1.02 1.37 .95 1.15 .95
KLA/ATP 1.64 1.69 1.39 1.51 1.04 1.31 1.26
Ccl1
KLA  ATP  ATP+KLA
 NM_011329 chemokine (C-C motif) ligand 1 (Ccl1), mRNA [NM_011329] KLA 1.03 1.04 1.07 1.10 1.03 1.03 1.10
ATP .99 .99 1.01 .99 1.02 .99 .93
KLA/ATP 1.06 1.08 1.04 1.03 .80 .96 1.00
Ccl11
KLA  ATP  ATP+KLA
 NM_011330 small chemokine (C-C motif) ligand 11 (Ccl11), mRNA [NM_011330] KLA 1.03 1.17 1.09 1.06 1.05 1.09 1.01
ATP .94 1.05 1.35 2.25 1.09 1.05 1.06
KLA/ATP 1.06 1.06 1.93 4.93 1.46 1.14 1.04
Ccl12
KLA  ATP  ATP+KLA
 NM_011331 chemokine (C-C motif) ligand 12 (Ccl12), mRNA [NM_011331] KLA 40.77 33.71 46.23 51.22 57.13 57.92 16.26
ATP 1.41 1.14 1.54 1.79 1.41 1.89 9.34
KLA/ATP 39.52 43.18 61.96 69.72 62.95 38.70 29.25
Ccl17
KLA  ATP  ATP+KLA
 NM_011332 chemokine (C-C motif) ligand 17 (Ccl17), mRNA [NM_011332] KLA 5.80 6.54 6.67 5.82 5.34 4.65 1.49
ATP 1.06 1.07 1.46 2.16 1.70 1.56 1.29
KLA/ATP 6.13 6.44 6.40 7.18 5.95 5.31 2.14
Ccl19
KLA  ATP  ATP+KLA
 NM_011888 chemokine (C-C motif) ligand 19 (Ccl19), mRNA [NM_011888] KLA 1.12 1.20 1.11 1.09 1.08 1.01 1.05
ATP .93 .99 1.01 1.01 .98 .95 1.03
KLA/ATP 1.12 1.21 1.16 1.13 1.08 .98 1.03
Ccl2
KLA  ATP  ATP+KLA
 NM_011333 chemokine (C-C motif) ligand 2 (Ccl2), mRNA [NM_011333] KLA 10.26 9.30 8.35 10.02 8.92 14.08 11.59
ATP 1.62 1.68 2.20 4.16 3.92 4.84 17.45
KLA/ATP 10.09 10.31 10.95 12.32 8.00 10.04 21.29
Ccl20
KLA  ATP  ATP+KLA
 NM_016960 chemokine (C-C motif) ligand 20 (Ccl20), mRNA [NM_016960] KLA 1.00 1.03 1.05 .98 1.02 1.06 1.08
ATP .98 1.01 1.05 1.11 1.04 1.03 1.02
KLA/ATP 1.06 .97 1.04 1.19 1.02 1.14 1.07
Ccl21b
KLA  ATP  ATP+KLA
 NM_011124 chemokine (C-C motif) ligand 21b (Ccl21b), mRNA [NM_011124] KLA 1.02 .97 .96 1.03 1.05 1.04 1.03
ATP .97 1.00 1.01 1.01 .94 1.03 1.01
KLA/ATP 1.08 .97 .96 1.00 1.06 1.03 1.02
Ccl22
KLA  ATP  ATP+KLA
 NM_009137 chemokine (C-C motif) ligand 22 (Ccl22), mRNA [NM_009137] KLA 2.72 3.55 5.08 2.98 3.72 1.76 1.17
ATP .98 1.01 1.20 1.21 1.44 1.44 1.15
KLA/ATP 3.64 4.28 2.52 3.64 2.47 2.27 1.32
Ccl24
KLA  ATP  ATP+KLA
 NM_019577 chemokine (C-C motif) ligand 24 (Ccl24), mRNA [NM_019577] KLA 8.39 10.31 8.99 8.13 7.85 6.70 2.42
ATP 1.07 1.07 1.43 1.55 2.08 10.12 7.27
KLA/ATP 8.67 10.73 9.89 10.16 7.70 7.70 6.46
Ccl25
KLA  ATP  ATP+KLA
 NM_009138 chemokine (C-C motif) ligand 25 (Ccl25), mRNA [NM_009138] KLA 1.12 1.13 1.03 1.14 1.19 1.50 1.35
ATP .97 .97 1.18 1.05 1.23 1.49 1.15
KLA/ATP 1.10 1.21 1.32 1.14 1.66 1.98 1.70
Ccl27
KLA  ATP  ATP+KLA
 NM_011336 chemokine (C-C motif) ligand 27 (Ccl27), transcript variant 1, mRNA [NM_011336] KLA .80 .85 .84 .81 .76 .71 .57
ATP .88 .77 .90 .81 .89 .79 .46
KLA/ATP .80 .81 .90 .80 .90 .82 .55
Ccl28
KLA  ATP  ATP+KLA
 NM_020279 chemokine (C-C motif) ligand 28 (Ccl28), mRNA [NM_020279] KLA .94 1.04 .95 1.00 .95 1.04 1.06
ATP 1.04 .98 1.01 .99 1.05 .99 1.09
KLA/ATP .98 .95 .95 1.03 1.06 .97 1.00
Ccl3
KLA  ATP  ATP+KLA
 NM_011337 chemokine (C-C motif) ligand 3 (Ccl3), mRNA [NM_011337] KLA 22.83 22.40 18.03 21.58 11.57 8.28 7.46
ATP 3.19 4.67 12.12 16.50 11.13 9.49 6.12
KLA/ATP 20.09 20.92 34.53 24.06 21.64 12.34 7.43
Ccl4
KLA  ATP  ATP+KLA
 NM_013652 chemokine (C-C motif) ligand 4 (Ccl4), mRNA [NM_013652] KLA 68.93 60.20 52.12 67.06 35.78 15.78 8.82
ATP 2.26 3.82 16.88 43.14 26.67 9.47 6.75
KLA/ATP 59.57 71.75 133.98 193.53 81.76 15.96 7.62
Ccl5
KLA  ATP  ATP+KLA
 M77747 rantes mRNA, complete cds. [M77747] KLA 63.18 60.41 56.25 63.63 58.00 66.51 67.20
ATP .91 1.08 1.25 1.90 4.34 16.10 26.07
KLA/ATP 55.92 63.34 72.91 65.68 70.81 71.97 81.34
Ccl5
KLA  ATP  ATP+KLA
 NM_013653 chemokine (C-C motif) ligand 5 (Ccl5), mRNA [NM_013653] KLA 40.31 35.22 27.92 38.59 29.29 37.98 28.83
ATP .86 .92 1.43 1.66 3.86 15.09 16.66
KLA/ATP 32.14 31.72 47.19 35.89 42.00 46.15 43.89
Ccl6
KLA  ATP  ATP+KLA
 NM_009139 chemokine (C-C motif) ligand 6 (Ccl6), mRNA [NM_009139] KLA .85 .90 .94 .99 1.09 .99 .61
ATP 1.08 1.10 .97 1.23 1.32 1.90 3.96
KLA/ATP .92 1.01 .81 .99 1.04 1.55 1.83
Ccl7
KLA  ATP  ATP+KLA
 NM_013654 chemokine (C-C motif) ligand 7 (Ccl7), mRNA [NM_013654] KLA 17.48 15.75 16.58 21.45 21.00 27.52 18.84
ATP 1.94 2.37 2.42 5.05 5.68 4.90 24.09
KLA/ATP 17.85 19.02 15.43 25.89 18.96 16.55 31.61
Ccl8
KLA  ATP  ATP+KLA
 NM_021443 chemokine (C-C motif) ligand 8 (Ccl8), mRNA [NM_021443] KLA 31.22 26.92 34.00 40.21 34.20 38.93 34.84
ATP 1.15 .93 1.43 1.60 1.78 2.89 30.88
KLA/ATP 30.86 28.87 45.73 35.24 41.83 42.79 55.40
Ccl9
KLA  ATP  ATP+KLA
 NM_011338 chemokine (C-C motif) ligand 9 (Ccl9), mRNA [NM_011338] KLA 3.82 4.17 4.36 4.26 5.84 5.09 2.07
ATP 1.03 1.05 .96 1.13 1.54 2.91 6.92
KLA/ATP 3.99 4.19 2.82 3.51 2.87 2.97 4.51
Ccr1
KLA  ATP  ATP+KLA
 NM_009912 chemokine (C-C motif) receptor 1 (Ccr1), mRNA [NM_009912] KLA 1.00 1.01 1.11 1.16 1.18 1.16 1.03
ATP 1.00 1.17 1.07 1.27 1.85 2.63 4.26
KLA/ATP .98 1.01 1.17 1.21 1.33 1.83 4.33
Ccr10
KLA  ATP  ATP+KLA
 NM_007721 chemokine (C-C motif) receptor 10 (Ccr10), mRNA [NM_007721] KLA 1.09 1.12 1.05 1.03 1.15 .97 .96
ATP .90 1.01 .97 .97 .98 1.02 1.00
KLA/ATP .97 .99 1.04 1.02 .97 .92 .97
Ccr1l1
KLA  ATP  ATP+KLA
 NM_007718 chemokine (C-C motif) receptor 1-like 1 (Ccr1l1), mRNA [NM_007718] KLA .91 .91 .93 .92 1.04 1.11 1.12
ATP 1.02 1.02 1.09 .98 .99 .98 1.36
KLA/ATP .99 .90 .89 .92 .91 .99 1.41
Ccr3
KLA  ATP  ATP+KLA
 NM_009914 chemokine (C-C motif) receptor 3 (Ccr3), mRNA [NM_009914] KLA 1.22 1.12 1.02 1.02 1.06 1.32 1.45
ATP 1.09 1.22 1.38 1.47 1.17 1.41 4.85
KLA/ATP 1.23 1.29 1.16 1.14 .80 .71 3.44
Ccr4
KLA  ATP  ATP+KLA
 NM_009916 chemokine (C-C motif) receptor 4 (Ccr4), mRNA [NM_009916] KLA .97 1.00 .99 1.00 1.06 1.06 1.05
ATP 1.03 .97 .98 1.05 .96 .99 1.07
KLA/ATP 1.01 1.01 .99 1.05 .98 .99 1.01
Ccr5
KLA  ATP  ATP+KLA
 NM_009917 chemokine (C-C motif) receptor 5 (Ccr5), mRNA [NM_009917] KLA .92 .90 1.34 1.58 1.78 1.69 2.02
ATP 1.09 1.04 1.14 1.01 .71 .62 1.40
KLA/ATP .96 .98 1.28 1.29 1.04 .67 1.57
Ccr6
KLA  ATP  ATP+KLA
 NM_009835 chemokine (C-C motif) receptor 6 (Ccr6), mRNA [NM_009835] KLA .99 1.01 1.06 1.00 .95 .97 .97
ATP 1.09 1.00 1.13 1.27 1.04 .99 .97
KLA/ATP 1.04 1.02 1.18 1.21 .98 .91 .97
Ccr7
KLA  ATP  ATP+KLA
 NM_007719 chemokine (C-C motif) receptor 7 (Ccr7), mRNA [NM_007719] KLA 1.58 1.73 2.00 1.95 2.02 1.77 1.60
ATP 1.07 1.06 1.21 2.11 2.85 2.72 1.78
KLA/ATP 1.76 1.95 3.23 4.65 5.17 5.76 4.07
Ccr8
KLA  ATP  ATP+KLA
 NM_007720 chemokine (C-C motif) receptor 8 (Ccr8), mRNA [NM_007720] KLA 1.05 .96 .95 1.04 1.02 1.05 1.02
ATP .98 1.02 1.06 1.00 .98 1.03 1.05
KLA/ATP .92 .93 1.02 .99 1.00 .97 1.11
Ccr9
KLA  ATP  ATP+KLA
 NM_009913 chemokine (C-C motif) receptor 9 (Ccr9), mRNA [NM_009913] KLA 1.49 1.42 1.94 1.73 1.61 1.31 1.26
ATP 1.19 1.03 1.17 1.26 1.34 1.41 1.12
KLA/ATP 1.58 1.64 1.64 1.64 1.40 1.41 1.42
Cdc42
KLA  ATP  ATP+KLA
 NM_009861 cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] KLA 1.04 1.01 1.02 1.04 1.12 1.21 1.12
ATP 1.07 1.10 1.04 1.06 1.02 .95 1.14
KLA/ATP .94 1.04 1.01 .97 .95 1.02 1.25
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Crk
KLA  ATP  ATP+KLA
 NM_133656 v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), mRNA [NM_133656] KLA 1.29 1.32 1.41 1.38 1.75 1.59 1.52
ATP 1.08 1.17 1.01 .93 1.27 2.11 1.70
KLA/ATP 1.37 1.49 1.14 1.09 1.21 1.69 2.32
Crkl
KLA  ATP  ATP+KLA
 NM_007764 v-crk sarcoma virus CT10 oncogene homolog (avian)-like (Crkl), mRNA [NM_007764] KLA 1.85 1.97 2.08 1.73 1.66 1.64 1.36
ATP .97 .94 .78 .74 1.46 1.89 1.46
KLA/ATP 1.92 1.88 1.18 1.44 1.67 2.65 2.72
Cx3cl1
KLA  ATP  ATP+KLA
 AB030188 mRNA, complete cds, clone:1-53. [AB030188] KLA 1.04 .94 1.03 1.04 .92 1.05 1.00
ATP .94 .96 .98 .96 1.02 .91 1.04
KLA/ATP 1.03 .99 .96 .98 .89 1.03 .99
Cx3cl1
KLA  ATP  ATP+KLA
 NM_009142 chemokine (C-X3-C motif) ligand 1 (Cx3cl1), mRNA [NM_009142] KLA 20.22 19.73 16.74 16.02 9.46 3.82 .33
ATP .91 .89 1.19 1.28 1.33 1.21 .55
KLA/ATP 17.11 18.99 24.51 16.85 12.70 6.17 .69
Cx3cr1
KLA  ATP  ATP+KLA
 NM_009987 chemokine (C-X3-C) receptor 1 (Cx3cr1), mRNA [NM_009987] KLA .73 .75 .66 .75 .72 .66 .67
ATP .96 1.11 .96 .96 .67 .62 .71
KLA/ATP .70 .69 .67 .71 .63 .57 .69
Cxcl1
KLA  ATP  ATP+KLA
 NM_008176 chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176] KLA 36.87 30.25 15.74 8.84 5.41 3.01 5.84
ATP 2.77 8.26 128.38 289.44 262.38 218.83 26.91
KLA/ATP 41.06 56.76 91.82 164.83 91.44 77.89 79.05
Cxcl10
KLA  ATP  ATP+KLA
 NM_021274 chemokine (C-X-C motif) ligand 10 (Cxcl10), mRNA [NM_021274] KLA 986.69 854.98 711.49 799.39 542.62 686.82 183.27
ATP .98 1.71 9.85 73.04 100.42 184.63 8.33
KLA/ATP 842.13 793.12 ###.## ###.## ###.## 715.22 496.10
Cxcl11
KLA  ATP  ATP+KLA
 NM_019494 chemokine (C-X-C motif) ligand 11 (Cxcl11), mRNA [NM_019494] KLA 53.93 53.81 51.26 58.57 51.83 57.67 21.56
ATP 1.04 1.02 1.56 1.81 1.84 5.79 2.13
KLA/ATP 48.25 51.73 69.50 55.47 41.98 48.57 57.88
Cxcl12
KLA  ATP  ATP+KLA
 NM_001012477 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 3, mRNA [NM_001012477] KLA .91 .91 .92 .92 .91 1.00 .85
ATP 1.00 .99 1.02 .99 .91 .93 .88
KLA/ATP .89 .91 .97 .97 .94 .93 .82
Cxcl12
KLA  ATP  ATP+KLA
 NM_021704 chemokine (C-X-C motif) ligand 12 (Cxcl12), transcript variant 1, mRNA [NM_021704] KLA 1.01 .96 1.04 1.04 .94 .98 .94
ATP 1.01 .92 .98 1.04 1.02 .94 .98
KLA/ATP 1.02 .98 1.07 .95 1.02 .98 .99
Cxcl13
KLA  ATP  ATP+KLA
 NM_018866 chemokine (C-X-C motif) ligand 13 (Cxcl13), mRNA [NM_018866] KLA 1.03 1.04 .98 1.05 .94 1.08 1.05
ATP 1.04 1.05 .99 1.13 1.04 1.04 1.03
KLA/ATP 1.01 1.06 .95 1.09 .98 1.02 .98
Cxcl14
KLA  ATP  ATP+KLA
 NM_019568 chemokine (C-X-C motif) ligand 14 (Cxcl14), mRNA [NM_019568] KLA 1.02 1.13 .93 .93 .88 .85 .82
ATP .86 1.01 1.26 1.47 1.30 1.29 1.32
KLA/ATP 1.04 1.07 1.02 1.38 1.12 1.30 1.30
Cxcl15
KLA  ATP  ATP+KLA
 NM_011339 chemokine (C-X-C motif) ligand 15 (Cxcl15), mRNA [NM_011339] KLA .97 .96 .96 .99 1.01 1.00 1.03
ATP .99 .98 .99 .99 1.01 1.06 1.06
KLA/ATP 1.03 .99 .96 1.02 .98 1.04 1.01
Cxcl16
KLA  ATP  ATP+KLA
 NM_023158 chemokine (C-X-C motif) ligand 16 (Cxcl16), mRNA [NM_023158] KLA 3.78 3.78 3.46 3.55 3.95 4.13 3.72
ATP .92 .87 .83 1.17 1.40 1.91 2.65
KLA/ATP 3.43 3.23 2.89 3.40 3.06 3.23 5.63
Cxcl2
KLA  ATP  ATP+KLA
 NM_009140 chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140] KLA 20.11 17.63 13.50 7.78 9.14 3.98 10.85
ATP 10.96 27.84 145.37 396.18 303.88 165.35 21.04
KLA/ATP 33.28 74.00 189.99 348.56 93.84 68.75 64.87
Cxcl3
KLA  ATP  ATP+KLA
 NM_203320 chemokine (C-X-C motif) ligand 3 (Cxcl3), mRNA [NM_203320] KLA 35.82 43.91 31.09 16.74 3.98 2.27 2.93
ATP 1.13 1.23 3.43 12.43 126.40 310.60 215.03
KLA/ATP 36.32 44.70 46.93 50.61 18.91 95.89 296.64
Cxcl5
KLA  ATP  ATP+KLA
 NM_009141 chemokine (C-X-C motif) ligand 5 (Cxcl5), mRNA [NM_009141] KLA 1.27 1.29 1.18 1.21 1.14 1.07 1.08
ATP 1.02 .99 1.08 1.10 1.92 18.34 20.38
KLA/ATP 1.27 1.26 1.26 1.24 1.23 4.06 29.52
Cxcl9
KLA  ATP  ATP+KLA
 NM_008599 chemokine (C-X-C motif) ligand 9 (Cxcl9), mRNA [NM_008599] KLA 47.92 43.81 42.05 48.89 39.45 45.28 32.42
ATP 1.00 1.02 1.43 1.62 1.59 2.25 1.96
KLA/ATP 41.95 43.69 63.75 56.28 60.18 53.62 48.95
Cxcr3
KLA  ATP  ATP+KLA
 NM_009910 chemokine (C-X-C motif) receptor 3 (Cxcr3), mRNA [NM_009910] KLA .38 .33 .29 .28 .19 .17 .13
ATP .97 .92 1.27 1.14 .87 .36 .37
KLA/ATP .37 .37 .42 .42 .35 .24 .26
Cxcr4
KLA  ATP  ATP+KLA
 NM_009911 chemokine (C-X-C motif) receptor 4 (Cxcr4), mRNA [NM_009911] KLA .30 .34 .26 .31 .25 .29 .42
ATP 1.27 2.70 6.37 11.61 7.04 1.14 4.92
KLA/ATP .28 .34 .56 2.60 3.47 1.23 1.28
Cxcr5
KLA  ATP  ATP+KLA
 NM_007551 chemochine (C-X-C motif) receptor 5 (Cxcr5), mRNA [NM_007551] KLA 1.18 1.29 1.48 1.43 1.40 1.48 1.27
ATP 1.05 1.00 1.08 1.05 1.16 1.22 1.37
KLA/ATP 1.35 1.32 1.05 1.36 1.25 1.57 1.54
Cxcr6
KLA  ATP  ATP+KLA
 NM_030712 chemokine (C-X-C motif) receptor 6 (Cxcr6), mRNA [NM_030712] KLA 1.17 1.20 1.20 1.17 1.14 1.24 1.22
ATP .94 .97 1.00 1.14 1.36 1.38 1.05
KLA/ATP 1.21 1.21 1.13 1.30 2.09 3.33 3.08
Dock2
KLA  ATP  ATP+KLA
 NM_033374 dedicator of cyto-kinesis 2 (Dock2), mRNA [NM_033374] KLA .97 .95 1.03 .73 .86 .81 1.01
ATP 1.05 1.18 .90 1.28 .77 .26 .73
KLA/ATP 1.07 1.12 .78 1.14 .54 .36 .78
Elmo1
KLA  ATP  ATP+KLA
 NM_198093 engulfment and cell motility 1, ced-12 homolog (C. elegans) (Elmo1), transcript variant 2, mRNA [NM_198093] KLA 1.36 1.37 1.16 1.20 1.02 .98 .72
ATP .88 .89 1.14 1.17 1.28 .78 .40
KLA/ATP 1.21 1.21 1.30 1.20 .98 .53 .51
Fgr
KLA  ATP  ATP+KLA
 NM_010208 Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog (Fgr), mRNA [NM_010208] KLA 2.84 2.96 3.09 3.96 5.21 4.30 5.46
ATP 1.01 1.01 1.09 1.14 1.03 1.11 1.37
KLA/ATP 2.68 2.99 2.38 2.68 1.80 1.28 1.88
Foxo3a
KLA  ATP  ATP+KLA
 AK079567 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230087I01 product:unclassifiable, full insert sequence. [AK079567] KLA .82 .81 .91 .83 .86 .86 .81
ATP .98 1.00 1.13 1.03 .97 .90 .82
KLA/ATP .86 .80 .90 .99 1.07 .84 .73
Foxo3a
KLA  ATP  ATP+KLA
 NM_019740 forkhead box O3a (Foxo3a), mRNA [NM_019740] KLA .94 .92 .86 .97 .87 1.04 1.04
ATP .99 1.09 1.06 .97 .96 1.07 1.15
KLA/ATP .90 .79 .90 .99 .95 1.04 1.11
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Gnb1
KLA  ATP  ATP+KLA
 NM_008142 guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] KLA 1.11 1.18 1.22 1.19 1.29 1.32 1.76
ATP 1.02 1.09 .84 .99 .97 .89 1.22
KLA/ATP 1.20 1.25 .85 1.01 .86 .91 1.57
Gnb2
KLA  ATP  ATP+KLA
 NM_010312 guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] KLA .94 .98 .94 1.08 1.23 1.32 1.16
ATP 1.04 .96 .59 .64 .59 .76 1.18
KLA/ATP 1.02 .84 .62 .64 .61 .89 1.36
Gnb3
KLA  ATP  ATP+KLA
 NM_013530 guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] KLA .99 1.00 .98 1.03 .94 .99 .96
ATP 1.01 1.02 .97 .95 1.01 .97 .92
KLA/ATP .99 1.02 1.02 .98 .99 .85 .99
Gnb4
KLA  ATP  ATP+KLA
 AK165084 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] KLA 4.61 4.10 4.23 2.41 2.25 1.59 .93
ATP 1.21 1.17 1.04 .81 2.92 1.50 1.03
KLA/ATP 5.86 6.56 3.60 1.68 5.62 3.00 1.37
Gnb4
KLA  ATP  ATP+KLA
 NM_013531 guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] KLA 8.41 8.09 10.57 9.44 6.06 2.97 .92
ATP 1.07 1.04 1.09 .87 1.48 2.10 1.18
KLA/ATP 8.14 8.93 9.12 7.69 5.03 5.11 2.37
Gnb5
KLA  ATP  ATP+KLA
 NM_010313 guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] KLA .68 .75 .67 .66 .53 .50 .65
ATP 1.03 1.08 1.09 1.14 .72 .54 .77
KLA/ATP .73 .70 .71 .73 .61 .65 .58
Gng10
KLA  ATP  ATP+KLA
 NM_025277 guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] KLA .95 .95 .86 .83 .70 .53 .43
ATP .93 1.03 1.17 1.21 .97 .60 .52
KLA/ATP .84 .91 .93 .99 .79 .47 .24
Gng11
KLA  ATP  ATP+KLA
 NM_025331 guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] KLA 1.30 1.26 1.44 1.54 1.26 1.42 1.90
ATP .88 .78 1.26 1.14 .90 .64 1.60
KLA/ATP 1.11 1.18 1.81 1.55 1.81 1.75 3.05
Gng12
KLA  ATP  ATP+KLA
 NM_025278 guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] KLA 2.21 2.23 2.48 2.62 2.47 2.28 1.68
ATP 1.02 1.02 1.09 1.10 1.20 1.32 1.01
KLA/ATP 2.10 2.17 2.38 2.40 1.91 1.60 1.77
Gng13
KLA  ATP  ATP+KLA
 NM_022422 guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] KLA 1.04 1.04 .94 1.00 1.00 1.05 .96
ATP 1.07 1.05 1.02 .94 .98 1.03 1.01
KLA/ATP 1.01 .99 1.05 1.01 1.01 .98 1.02
Gng2
KLA  ATP  ATP+KLA
 NM_010315 guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] KLA .79 .81 .81 .82 .67 .57 .75
ATP 1.02 1.01 1.13 1.35 1.48 1.01 1.31
KLA/ATP .79 .86 .97 1.05 1.29 1.00 .84
Gng3
KLA  ATP  ATP+KLA
 NM_010316 guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] KLA 1.00 .98 1.02 .95 .99 1.00 1.06
ATP .98 1.05 .99 1.03 1.05 1.03 .97
KLA/ATP 1.01 1.00 1.07 1.01 1.04 1.04 1.05
Gng4
KLA  ATP  ATP+KLA
 NM_010317 guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] KLA 1.27 1.26 1.47 1.30 1.15 1.13 .82
ATP 1.05 .97 1.07 1.62 3.97 3.46 1.24
KLA/ATP 1.35 1.32 1.37 1.35 1.64 2.18 1.56
Gng5
KLA  ATP  ATP+KLA
 NM_010318 guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] KLA .94 .84 .80 1.12 .98 1.11 1.29
ATP 1.07 1.01 1.07 1.05 1.17 1.52 1.01
KLA/ATP .83 .94 1.27 1.17 1.19 1.35 1.36
Gng7
KLA  ATP  ATP+KLA
 NM_001038655 guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] KLA .92 .96 .87 .91 .83 .98 .98
ATP 1.04 1.06 .98 .95 .81 .77 .75
KLA/ATP .97 .95 .81 .91 .79 .77 .81
Gng8
KLA  ATP  ATP+KLA
 NM_010320 guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] KLA .93 .93 .95 .96 .90 .88 1.09
ATP .95 .90 1.01 .92 1.04 1.01 1.05
KLA/ATP .97 1.03 .99 .90 1.10 .99 1.04
Gngt1
KLA  ATP  ATP+KLA
 NM_010314 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] KLA 1.06 .99 .95 .98 1.03 1.10 .98
ATP .96 1.02 1.03 1.03 .94 1.06 .95
KLA/ATP .98 1.03 1.04 1.04 1.01 1.03 1.01
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Grk1
KLA  ATP  ATP+KLA
 NM_011881 G protein-coupled receptor kinase 1 (Grk1), mRNA [NM_011881] KLA 1.10 1.03 .96 .96 1.08 .98 1.01
ATP 1.04 .99 .95 1.04 1.03 .96 1.06
KLA/ATP .99 1.05 .95 1.02 1.05 1.02 1.06
Grk4
KLA  ATP  ATP+KLA
 NM_019497 G protein-coupled receptor kinase 4 (Grk4), transcript variant 1, mRNA [NM_019497] KLA 1.05 1.03 .98 1.16 .96 .95 .95
ATP .95 .97 1.12 1.09 .93 .95 1.13
KLA/ATP 1.04 1.05 1.14 1.04 .95 .97 1.03
Grk5
KLA  ATP  ATP+KLA
 NM_018869 G protein-coupled receptor kinase 5 (Grk5), mRNA [NM_018869] KLA 1.38 1.35 1.36 1.01 .70 .60 1.49
ATP .96 .99 1.20 1.19 .81 2.59 1.98
KLA/ATP 1.35 1.31 1.41 1.23 .68 1.16 2.94
Grk6
KLA  ATP  ATP+KLA
 NM_001038018 G protein-coupled receptor kinase 6 (Grk6), transcript variant 1, mRNA [NM_001038018] KLA .41 .46 .43 .47 .69 .79 .75
ATP 1.03 1.09 .81 .90 .61 .65 .50
KLA/ATP .48 .45 .36 .43 .40 .54 .40
Grk6
KLA  ATP  ATP+KLA
 NM_011938 G protein-coupled receptor kinase 6 (Grk6), transcript variant 2, mRNA [NM_011938] KLA .71 .72 .69 .71 .82 .94 .80
ATP 1.04 1.15 .93 1.06 .69 .78 .65
KLA/ATP .74 .70 .65 .70 .56 .72 .55
Gsk3a
KLA  ATP  ATP+KLA
 NM_001031667 glycogen synthase kinase 3 alpha (Gsk3a), mRNA [NM_001031667] KLA 1.19 1.26 1.29 1.10 1.24 1.21 1.44
ATP 1.06 1.31 1.01 1.69 1.17 1.08 1.24
KLA/ATP 1.34 1.35 .91 1.49 .97 1.10 1.51
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Hck
KLA  ATP  ATP+KLA
 NM_010407 hemopoietic cell kinase (Hck), mRNA [NM_010407] KLA 4.59 4.25 4.84 6.31 7.85 6.43 4.34
ATP 1.05 1.02 .84 .84 1.12 1.82 1.55
KLA/ATP 4.31 4.18 4.53 3.92 4.14 3.10 4.00
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il8ra
KLA  ATP  ATP+KLA
 NM_178241 interleukin 8 receptor, alpha (Il8ra), mRNA [NM_178241] KLA .96 1.09 1.01 1.02 .92 .93 .95
ATP .95 .99 .88 .99 1.02 1.02 .96
KLA/ATP 1.01 1.03 .92 .99 1.02 1.02 1.00
Il8rb
KLA  ATP  ATP+KLA
 NM_009909 interleukin 8 receptor, beta (Il8rb), mRNA [NM_009909] KLA 1.05 1.01 1.06 .98 1.06 1.06 .85
ATP .98 .96 .99 .94 .98 .96 1.05
KLA/ATP 1.01 .93 1.04 .92 .98 .98 .99
Itk
KLA  ATP  ATP+KLA
 AK037554 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026F16 product:IL2-inducible T-cell kinase, full insert sequence. [AK037554] KLA .89 .95 .91 .89 .94 .76 .70
ATP 1.07 .97 .98 .88 .69 .59 .70
KLA/ATP .98 .96 .84 .86 .72 .60 .49
Itk
KLA  ATP  ATP+KLA
 NM_010583 IL2-inducible T-cell kinase (Itk), mRNA [NM_010583] KLA 1.10 1.22 1.29 1.17 1.15 1.10 1.18
ATP 1.00 1.01 1.04 .97 1.00 .93 1.00
KLA/ATP 1.28 1.22 1.16 1.06 .95 1.00 1.15
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Lyn
KLA  ATP  ATP+KLA
 NM_010747 Yamaguchi sarcoma viral (v-yes-1) oncogene homolog (Lyn), transcript variant 2, mRNA [NM_010747] KLA 2.48 2.80 3.76 3.81 5.30 4.57 2.46
ATP 1.06 1.18 .82 .97 .74 1.45 1.21
KLA/ATP 2.82 3.16 2.24 2.87 1.73 1.80 2.63
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mm.11707
6
KLA  ATP  ATP+KLA
 124001565 Unknown KLA .78 .79 .79 .78 .79 .68 .78
ATP 1.04 1.01 1.18 .95 .89 1.00 1.32
KLA/ATP .80 .88 .95 .83 .85 .85 .83
Mm.20374
7
KLA  ATP  ATP+KLA
 146149233 Unknown KLA .34 .30 .28 .41 .80 1.31 1.29
ATP .93 .83 .82 .76 .43 .46 .88
KLA/ATP .30 .28 .27 .27 .27 .51 1.11
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.23446
6
KLA  ATP  ATP+KLA
 87299639 Unknown KLA .92 1.02 1.03 1.00 1.00 1.10 1.07
ATP 1.03 1.01 1.12 .94 1.03 .91 1.01
KLA/ATP .98 1.00 1.03 1.05 1.04 1.11 1.03
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.27166
5
KLA  ATP  ATP+KLA
 171542818 Unknown KLA 1.54 1.51 1.60 1.85 2.41 2.03 2.49
ATP 1.06 1.07 1.03 1.04 .88 1.05 1.11
KLA/ATP 1.61 1.54 1.31 1.32 1.16 1.00 1.23
Mm.27492
7
KLA  ATP  ATP+KLA
 157012006 Unknown KLA 1.53 1.40 2.02 2.77 2.61 2.39 1.11
ATP 1.08 1.25 2.14 3.10 7.35 20.10 23.05
KLA/ATP 1.38 1.67 2.98 4.34 6.46 11.28 28.93
Mm.2932
KLA  ATP  ATP+KLA
 116268120 Unknown KLA 1.74 1.87 2.38 2.24 2.14 1.97 1.66
ATP 1.06 .97 1.25 2.61 3.26 3.23 1.78
KLA/ATP 2.10 2.32 3.52 5.43 5.89 6.74 4.66
Mm.29466
4
KLA  ATP  ATP+KLA
 72384360 Unknown KLA .99 .96 .88 .92 .89 .95 1.29
ATP 1.02 1.06 1.02 1.21 1.09 1.05 1.00
KLA/ATP .96 .91 .79 1.01 .96 1.11 1.29
Mm.30211
KLA  ATP  ATP+KLA
 119392097 Unknown KLA 1.01 1.08 .87 .90 .84 .79 .76
ATP .90 1.00 1.29 1.51 1.34 1.32 1.26
KLA/ATP .94 1.04 1.10 1.33 1.09 1.34 1.34
Mm.34239
2
KLA  ATP  ATP+KLA
 17933765 Unknown KLA 1.15 1.31 1.31 1.04 1.09 1.04 .91
ATP 1.07 1.37 .89 1.59 1.14 .71 .54
KLA/ATP 1.44 1.37 .75 1.45 .66 .56 .68
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.42529
6
KLA  ATP  ATP+KLA
 170172552 Unknown KLA 1.51 1.59 1.64 1.57 1.87 1.40 1.91
ATP 1.02 1.04 .77 .91 .52 .49 1.04
KLA/ATP 1.63 1.53 1.11 1.32 .80 .69 1.23
Mm.44050
5
KLA  ATP  ATP+KLA
 84579905 Unknown KLA 1.03 .96 .90 1.03 .94 1.15 1.23
ATP .88 .91 1.15 1.18 1.17 1.31 1.02
KLA/ATP .87 .97 1.19 1.18 1.36 1.34 1.25
Ncf1
KLA  ATP  ATP+KLA
 NM_010876 neutrophil cytosolic factor 1 (Ncf1), mRNA [NM_010876] KLA 1.62 1.71 1.81 1.70 1.99 1.64 2.07
ATP 1.02 1.06 .78 1.02 .64 .56 1.08
KLA/ATP 1.87 1.81 1.22 1.73 1.00 .80 1.49
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Pak1
KLA  ATP  ATP+KLA
 NM_011035 p21 (CDKN1A)-activated kinase 1 (Pak1), mRNA [NM_011035] KLA .72 .77 .79 .71 .67 .73 .95
ATP 1.10 1.07 .99 1.15 1.27 .62 .51
KLA/ATP .85 .83 .73 .76 .76 .55 .33
Pard3
KLA  ATP  ATP+KLA
 AK076429 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832405A21 product:par-3 (partitioning defective 3) homolog (C. elegans), full insert sequence. [AK076429] KLA .96 .96 1.03 .96 1.03 .99 1.19
ATP .97 .92 1.09 .99 1.00 1.03 .94
KLA/ATP .97 1.01 .97 1.05 .98 .92 1.04
Pard3
KLA  ATP  ATP+KLA
 NM_001013580 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 2, mRNA [NM_001013580] KLA 1.02 .99 1.03 .97 1.00 .97 1.04
ATP .93 1.02 .98 .95 1.02 1.02 .98
KLA/ATP 1.04 .98 1.01 .99 .96 .91 .95
Pard3
KLA  ATP  ATP+KLA
 NM_001013581 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 1, mRNA [NM_001013581] KLA .99 1.06 1.02 1.02 1.00 .98 .95
ATP .91 1.05 1.06 .99 1.04 .89 .99
KLA/ATP .98 .97 1.09 .97 1.01 .98 1.00
Pard3
KLA  ATP  ATP+KLA
 NM_001122850 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 4, mRNA [NM_001122850] KLA 1.01 .95 1.00 1.01 1.07 .91 .99
ATP 1.00 1.01 .98 .94 1.04 .98 1.00
KLA/ATP .99 .99 1.04 1.04 1.04 1.01 1.03
Pard3
KLA  ATP  ATP+KLA
 NM_033620 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 3, mRNA [NM_033620] KLA .92 .93 .97 .96 1.00 .99 1.02
ATP 1.08 1.03 .93 .92 .99 .97 1.00
KLA/ATP .99 1.03 1.02 1.05 .96 1.06 1.03
Pf4
KLA  ATP  ATP+KLA
 NM_019932 platelet factor 4 (Pf4), mRNA [NM_019932] KLA .98 .95 .88 .91 .77 .67 .29
ATP .95 .95 .97 .91 .87 1.79 9.27
KLA/ATP .91 .88 .91 .96 .75 .87 2.12
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Ppbp
KLA  ATP  ATP+KLA
 NM_023785 pro-platelet basic protein (Ppbp), mRNA [NM_023785] KLA 1.17 1.27 1.09 1.25 1.09 1.02 .63
ATP .96 .89 1.10 1.14 1.55 10.17 70.24
KLA/ATP 1.16 1.04 1.19 1.26 1.27 3.28 10.96
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcd
KLA  ATP  ATP+KLA
 NM_011103 protein kinase C, delta (Prkcd), mRNA [NM_011103] KLA 1.72 1.84 1.90 1.68 2.01 1.61 1.64
ATP 1.00 1.03 .68 .81 1.38 1.26 .98
KLA/ATP 1.77 1.79 1.16 1.19 1.33 1.25 1.56
Prkcz
KLA  ATP  ATP+KLA
 NM_008860 protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] KLA .92 .90 1.00 .99 1.07 1.05 1.12
ATP 1.01 .95 .94 .93 1.04 1.04 .95
KLA/ATP .95 .94 .95 .94 .99 1.02 .98
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ptk2
KLA  ATP  ATP+KLA
 NM_007982 PTK2 protein tyrosine kinase 2 (Ptk2), mRNA [NM_007982] KLA .99 .99 1.02 1.04 1.09 1.22 1.57
ATP 1.04 1.09 .95 .98 .67 .96 .87
KLA/ATP .99 1.03 .87 .93 .81 1.16 1.04
Ptk2b
KLA  ATP  ATP+KLA
 NM_172498 PTK2 protein tyrosine kinase 2 beta (Ptk2b), mRNA [NM_172498] KLA 1.34 1.39 1.78 1.70 2.36 2.26 1.77
ATP 1.08 1.21 .59 .69 .65 .71 1.17
KLA/ATP 1.41 1.55 1.07 1.33 1.07 1.24 1.80
Pxn
KLA  ATP  ATP+KLA
 AK084243 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230012N01 product:inferred: paxillin beta {Homo sapiens}, full insert sequence. [AK084243] KLA 1.06 .92 1.01 .95 .97 .97 1.02
ATP 1.02 1.02 .97 .90 .98 .94 .89
KLA/ATP .96 .97 .98 .91 1.01 1.00 .94
Pxn
KLA  ATP  ATP+KLA
 NM_133915 paxillin (Pxn), transcript variant beta, mRNA [NM_133915] KLA 1.13 1.13 1.14 1.14 1.49 1.60 1.30
ATP 1.11 1.22 .86 1.04 1.14 1.18 1.35
KLA/ATP 1.41 1.22 .80 .92 1.07 1.54 2.60
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rac2
KLA  ATP  ATP+KLA
 NM_009008 RAS-related C3 botulinum substrate 2 (Rac2), mRNA [NM_009008] KLA 1.55 1.68 1.86 2.15 3.36 3.59 3.74
ATP 1.13 1.16 .74 .99 .84 .91 1.66
KLA/ATP 1.59 1.71 1.19 1.56 1.21 1.60 3.48
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Rap1a
KLA  ATP  ATP+KLA
 AK030897 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830450G12 product:RAS-related protein-1a, full insert sequence [AK030897] KLA .83 .80 .92 1.04 1.06 .91 1.06
ATP 1.04 .92 1.11 1.03 1.05 .73 .72
KLA/ATP .83 .81 .97 .75 1.14 .71 .53
Rap1a
KLA  ATP  ATP+KLA
 NM_145541 RAS-related protein-1a (Rap1a), mRNA [NM_145541] KLA .87 .78 .76 .86 .86 .84 1.01
ATP .91 .95 1.33 1.20 1.27 1.04 .81
KLA/ATP .68 .75 .92 .85 1.13 .90 .74
Rap1b
KLA  ATP  ATP+KLA
 M79314 GTP-binding protein RAP1b mRNA, partial cds. [M79314] KLA 2.61 2.95 2.81 2.76 3.07 2.67 1.88
ATP 1.00 1.10 1.00 1.94 1.94 1.72 1.31
KLA/ATP 2.49 2.45 2.03 4.23 3.03 2.60 1.86
Rap1b
KLA  ATP  ATP+KLA
 NM_024457 RAS related protein 1b (Rap1b), mRNA [NM_024457] KLA 2.21 2.35 2.71 2.51 2.86 2.44 1.54
ATP 1.05 .92 .93 1.14 1.30 1.26 1.07
KLA/ATP 2.23 2.15 1.57 2.53 2.16 1.67 1.38
Rasgrp2
KLA  ATP  ATP+KLA
 NM_011242 RAS, guanyl releasing protein 2 (Rasgrp2), mRNA [NM_011242] KLA .99 1.04 1.01 .96 1.02 1.07 1.09
ATP .94 1.02 .98 1.08 1.02 1.04 1.00
KLA/ATP 1.01 1.04 .96 1.06 1.05 1.06 .96
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Rock1
KLA  ATP  ATP+KLA
 NM_009071 Rho-associated coiled-coil containing protein kinase 1 (Rock1), mRNA [NM_009071] KLA 2.40 2.48 2.37 3.07 1.94 1.42 1.21
ATP .95 .92 .87 .70 1.13 1.74 .98
KLA/ATP 2.27 2.35 2.56 1.60 1.65 1.56 1.23
Rock2
KLA  ATP  ATP+KLA
 NM_009072 Rho-associated coiled-coil containing protein kinase 2 (Rock2), mRNA [NM_009072] KLA .99 .92 .83 .87 .73 .74 1.04
ATP 1.07 1.31 1.16 1.02 1.02 1.03 .88
KLA/ATP 1.00 1.07 .93 .85 .69 .63 .81
Shc1
KLA  ATP  ATP+KLA
 NM_011368 src homology 2 domain-containing transforming protein C1 (Shc1), transcript variant 2, mRNA [NM_011368] KLA .88 .87 .86 .83 1.09 1.11 1.12
ATP 1.04 1.25 .85 1.17 .93 1.16 1.00
KLA/ATP .93 .96 .62 .96 .75 1.25 1.19
Shc2
KLA  ATP  ATP+KLA
 NM_001024539 src homology 2 domain-containing transforming protein C2 (Shc2), mRNA [NM_001024539] KLA 1.19 1.25 1.22 1.16 1.15 1.14 .98
ATP 1.04 1.14 1.15 1.53 1.29 1.06 1.09
KLA/ATP 1.26 1.24 1.26 1.49 1.31 1.30 1.30
Shc3
KLA  ATP  ATP+KLA
 NM_009167 src homology 2 domain-containing transforming protein C3 (Shc3), mRNA [NM_009167] KLA 1.00 .98 1.06 1.06 1.12 1.08 1.04
ATP .99 1.02 1.00 1.05 1.00 1.08 1.08
KLA/ATP 1.08 1.06 1.01 1.06 1.03 1.12 1.41
Shc4
KLA  ATP  ATP+KLA
 NM_199022 SHC (Src homology 2 domain containing) family, member 4 (Shc4), mRNA [NM_199022] KLA 1.03 1.03 1.01 1.06 1.09 1.03 1.06
ATP .99 1.00 1.03 1.02 1.04 1.04 1.01
KLA/ATP .98 .97 1.06 1.05 1.00 1.00 1.14
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Stat5b
KLA  ATP  ATP+KLA
 AK137889 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130035C01 product:unclassifiable, full insert sequence. [AK137889] KLA 1.10 1.01 .98 .90 1.03 .93 .88
ATP .90 .87 .61 .69 1.01 .97 .89
KLA/ATP 1.12 1.00 .87 .85 .95 1.07 .83
Stat5b
KLA  ATP  ATP+KLA
 NM_011489 signal transducer and activator of transcription 5B (Stat5b), transcript variant 1, mRNA [NM_011489] KLA 2.91 2.81 3.42 2.69 2.23 1.95 1.32
ATP .99 1.04 1.16 .97 1.00 1.84 2.09
KLA/ATP 2.96 3.05 3.17 2.99 1.86 1.87 3.40
Tiam1
KLA  ATP  ATP+KLA
 NM_009384 T-cell lymphoma invasion and metastasis 1 (Tiam1), mRNA [NM_009384] KLA 1.72 1.71 2.10 1.75 1.43 .71 .27
ATP 1.04 1.03 .79 .88 .90 .72 1.07
KLA/ATP 1.79 1.84 1.46 1.43 .90 .87 .73
Vav1
KLA  ATP  ATP+KLA
 NM_011691 vav 1 oncogene (Vav1), mRNA [NM_011691] KLA .79 .83 .98 1.17 1.97 2.42 2.26
ATP 1.06 1.02 .88 1.01 1.34 .82 1.36
KLA/ATP .88 .85 .73 .78 1.25 1.47 2.17
Vav2
KLA  ATP  ATP+KLA
 BC053060 vav 2 oncogene, mRNA (cDNA clone MGC:62363 IMAGE:5704852), complete cds [BC053060] KLA .73 .58 .55 1.16 .76 1.35 1.75
ATP .99 .89 .79 .82 .67 .85 1.09
KLA/ATP .64 .63 .61 .65 .66 .80 1.23
Vav2
KLA  ATP  ATP+KLA
 NM_009500 vav 2 oncogene (Vav2), mRNA [NM_009500] KLA .98 1.05 .98 .99 1.02 1.36 1.43
ATP 1.07 1.06 .96 1.01 .89 .95 1.08
KLA/ATP 1.04 1.05 .98 1.03 .88 .99 1.13
Vav3
KLA  ATP  ATP+KLA
 NM_020505 vav 3 oncogene (Vav3), transcript variant 1, mRNA [NM_020505] KLA .95 .94 .86 .87 .82 .66 .56
ATP 1.06 1.09 .81 1.05 .80 .75 .85
KLA/ATP 1.00 .84 .62 .85 .74 .56 .74
Was
KLA  ATP  ATP+KLA
 NM_009515 Wiskott-Aldrich syndrome homolog (human) (Was), mRNA [NM_009515] KLA .66 .67 .64 .65 .88 1.08 1.09
ATP 1.08 1.11 .87 1.23 .77 .51 .90
KLA/ATP .76 .70 .44 .83 .49 .61 .91
Wasl
KLA  ATP  ATP+KLA
 NM_028459 Wiskott-Aldrich syndrome-like (human) (Wasl), mRNA [NM_028459] KLA .88 .89 .96 .85 .97 1.08 1.14
ATP 1.08 .99 .71 .76 1.71 .91 .99
KLA/ATP .96 .84 .72 .84 1.51 .91 1.24
Xcl1
KLA  ATP  ATP+KLA
 NM_008510 chemokine (C motif) ligand 1 (Xcl1), mRNA [NM_008510] KLA 1.02 1.00 .97 1.00 1.05 1.01 1.08
ATP 1.06 .99 1.07 1.05 1.06 1.04 1.05
KLA/ATP 1.07 1.04 1.04 1.02 1.06 1.05 1.09
Xcr1
KLA  ATP  ATP+KLA
 NM_011798 chemokine (C motif) receptor 1 (Xcr1), mRNA [NM_011798] KLA 1.13 1.14 1.18 1.15 1.16 1.16 1.06
ATP 1.03 .99 1.13 1.18 1.23 1.13 1.05
KLA/ATP 1.17 1.26 1.29 1.29 1.30 1.35 1.14